Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Phase III Trial Evaluating the Impact of Hysterectomy After Chemoradiation Therapy for Stage IB2/II Cervical Cancer

NCT01363466 is registered in ClinicalTrials.gov with UNICANCER as lead sponsor.

NCT NCT01363466
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01363466 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Phase III Trial Evaluating the Impact of Hysterectomy After Chemoradiation Therapy for Stage IB2/II Cervical Cancer
Lead sponsor
UNICANCER
Phase
Phase 3
Overall status
Terminated
Start date
May 31, 2003
Completion date
November 30, 2006
Enrollment
61 (actual)
Sites
35

Conditions

As the registry lists them; a condition with its own page is linked.

adenocarcinoma, adenosquamous carcinoma, squamous cell carcinoma, stage ib2 cervical cancer, stage ii cervical cancer